BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1971329)

  • 1. Autotransplants in chronic myelogenous leukaemia: strategies and results.
    Butturini A; Keating A; Goldman J; Gale RP
    Lancet; 1990 May; 335(8700):1255-8. PubMed ID: 1971329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia depends on percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells.
    Talpaz M; Kantarjian H; Liang J; Calvert L; Hamer J; Tibbits P; Durett A; Claxton D; Giralt S; Khouri I
    Blood; 1995 Jun; 85(11):3257-63. PubMed ID: 7756658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical models of autotransplants in chronic myelogenous leukemia.
    Butturini A; Gale RP
    Leuk Lymphoma; 1993; 11 Suppl 1():255-7. PubMed ID: 8251906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of autotransplants in chronic myeloid leukaemia.
    Goldman JM; Deisseroth AB
    Bone Marrow Transplant; 1992; 10 Suppl 1():74-6. PubMed ID: 1355687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
    Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
    Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow transplants in chronic myelogenous leukemia: an overview of determinants of survival.
    McGlave P
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):23-30. PubMed ID: 1695763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups.
    McGlave PB; De Fabritiis P; Deisseroth A; Goldman J; Barnett M; Reiffers J; Simonsson B; Carella A; Aeppli D
    Lancet; 1994 Jun; 343(8911):1486-8. PubMed ID: 7911185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous transplant for CML revisited.
    Daley GQ; Goldman JM
    Exp Hematol; 1993 Jun; 21(6):734-7. PubMed ID: 8500574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of relapse after bone marrow transplantation for chronic myeloid leukaemia.
    Frassoni F; Sessarego M; Martinelli G; Strada P; Gualandi F; Lamparelli T; Pignatti PF; Defferrari R; Fugazza G; Bacigalupo A
    Bone Marrow Transplant; 1991; 7 Suppl 2():17-8. PubMed ID: 1878694
    [No Abstract]   [Full Text] [Related]  

  • 12. Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase.
    Meloni G; De Fabritiis P; Alimena G; Malagnino F; Montefusco E; Sandrelli A; Pinto R; Vignetti M; Lo Coco F; Mandelli F
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():92-4. PubMed ID: 2576389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture purging in leukemia: past, present, and future.
    Eaves AC; Eaves CJ; Phillips GL; Barnett MJ
    Leuk Lymphoma; 1993; 11 Suppl 1():259-63. PubMed ID: 8251907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autografting in chronic myelogenous leukemia: new questions.
    Carella AM; Frassoni F; Negrin RS
    Leukemia; 1995 Mar; 9(3):365-9. PubMed ID: 7885034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous transplantation for CML using marrow treated ex vivo with recombinant human interferon gamma.
    McGlave PB; Arthur D; Miller WJ; Lasky L; Kersey J
    Bone Marrow Transplant; 1990 Aug; 6(2):115-20. PubMed ID: 2119838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study.
    Barnett MJ; Eaves CJ; Phillips GL; Gascoyne RD; Hogge DE; Horsman DE; Humphries RK; Klingemann HG; Lansdorp PM; Nantel SH
    Blood; 1994 Aug; 84(3):724-32. PubMed ID: 8043861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow transplantation for chronic myelogenous leukemia: clinical outcomes.
    Enright H; Davies S; McGlave P
    Clin Transpl; 1994; ():283-93. PubMed ID: 7547549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R; Ritz J; Anderson KC
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):369-88. PubMed ID: 2182597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.
    Rowe JM; Rapoport AP; Ryan DH; Nilsson BI; Duerst RE; Packman CH; Abboud CN; DiPersio JF; Linder T; Wang N; Simonsson B; Liesveld JL
    Bone Marrow Transplant; 1999 Nov; 24(10):1057-63. PubMed ID: 10578155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood stem cell autografts in CML.
    Hoyle C; Goldman J
    Leuk Lymphoma; 1993; 11 Suppl 1():271-5. PubMed ID: 7504545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.